|
|
Title | Creator | Date |
| 126 |
 |
Progressive optic neuropathy in idiopathic intracranial hypertension after optic nerve sheath fenestration. | Wilkes, Byron N; Siatkowski, R Michael | |
| 127 |
 |
Positional Obstruction of Ventriculoperitoneal Shunt in a Patient With Idiopathic Intracranial Hypertension | Laura Donaldson; Elie Côté; Edward Margolin | 2022-12 |
| 128 |
 |
What is the Current Status of Optic Nerve Sheath Fenestration? | James A. Garrity, MD | 2016-09 |
| 129 |
 |
Idiopathic Intracranial Hypertension Induced by Topical Application of Vitamin A | Yousef M. Mohammad, MD, MSc; Ismail R. Raslan, MD; Fawaz A. Al-Hussain, MD, MPH | 2016-12 |
| 130 |
 |
Intravitreal Bevacizumab in the Treatment of Peripapillary Choroidal Neovascular Membrane Secondary to Idiopathic Intracranial Hypertension | In-Jung Lee, BSc, BAppSc, MBBS; Luke J. Maccheron, BMedSc, MBBS, FRANZCO; Anthony S. Kwan, MBChB, MD, FRCOphth, FRANZCO | 2013-06 |
| 131 |
 |
Absence of the relative afferent pupillary defect with monocular temporal visual field loss. | Kosmorsky, G.S.; Tomsak, R.L.; Diskin, D.K. | |
| 132 |
 |
Papilledema in paroxysmal nocturnal hemoglobinuria. | Aktan, S.; Kansu, T.; Kansu, E.; Zileli, T. | |
| 133 |
 |
Spontaneous Cerebrospinal Fluid Otorrhea and Rhinorrhea in Idiopathic Intracranial Hypertension Patients | Eldar Rosenfeld, MD; Gad Dotan, MD; Tali J. Kimchi, MD; Anat Kesler, MD | 2013-06 |
| 134 |
 |
Correlation Between Optic Disc Peripapillary Capillary Network and Papilledema Grading in Patients With Idiopathic Intracranial Hypertension: A Study of Optical Coherence Tomography Angiography | Yasaira Rodriguez Torres; Patrick Lee; Melanie Mihlstin; Robert L. Tomsak | 2021-03 |
| 135 |
 |
Optical Coherence Tomography Should Be Used Routinely to Monitor Patients With Idiopathic Intracranial Hypertension | John J. Chen, MD, PhD; Jonathan D. Trobe, MD | 2016-12 |
| 136 |
 |
Complications of Ventriculoperitoneal Shunt for Idiopathic Intracranial Hypertension: A Single-Institution Study of 32 Patients | Anthony J. Brune; Taania Girgla; Jonathan D. Trobe | 2021-06 |
| 137 |
 |
The Idiopathic Intracranial Hypertension Treatment Trial: Design Considerations and Methods | Friedman, Deborah I; McDermott, Michael P; Kieburtz, Karl; Kupersmith, Mark; Stoutenburg, Ann; Keltner, John L; Feldon, Steven E; Schron, Eleanor; Corbett, James J; Wall, Michael | |
| 138 |
 |
Transient cortical blindness due to hypertensive encephalopathy. Magnetic resonance imaging correlation. | Marra, T.R.; Shah, M.; Mikus, M.A. | |
| 139 |
 |
Ocular Ischemic Syndrome Secondary to Inflammatory Pseudotumor of the Skull Base Masquerading as Giant Cell Arteritis | Mišo Gostimir; Bret John Wehrli; J. Alexander Fraser | 2021-09 |
| 140 |
 |
Idiopathic Intracranial Hypertension: Relation Between Obesity and Visual Outcomes | Szewka, Aimee J; Bruce, Beau B; Newman, Nancy J; Biousse, Valrie | |
| 141 |
|
Idiopathic Intracranial Hypertension: Relation Between Obesity and Visual Outcomes | Aimee J. Szewka, MD; Beau B. Bruce, MD; Nancy J. Newman, MD; Valérie Biousse, MD | 2013-03 |
| 142 |
 |
Superonasal Transconjunctival Optic Nerve Sheath Decompression: A Simplified Technique for Safe and Efficient Decompression | Andrew T. Melson; Jacob D. Warmath; Annie Moreau; Bradley K. Farris | 2021-03 |
| 143 |
 |
Inpatient and Emergency Service Utilization in Patients With Idiopathic Intracranial Hypertension | Koerner, Jagger C; Friedman, Deborah I | |
| 144 |
 |
Thinning of the Skull Base and Calvarial Thickness in Patients With Idiopathic Intracranial Hypertension | Matthew Barke; Hannah Muniz Castro; Ore-Ofe O. Adesina; Alice Z. Chuang; Thai Do; Rajan P. Patel; Karina Richani | 2022-06 |
| 145 |
 |
Identifying Incidence of and Risk Factors for Fluoroscopy-Guided Lumbar Puncture and Subsequent Persistent Low-Pressure Syndrome in Patients With Idiopathic Intracranial Hypertension | Patricia Lu; Manu Goyal; Julia B. Huecker; Mae O. Gordon; Gregory P. Van Stavern | 2019-06 |
| 146 |
 |
Peripapillary Vessel Density Measured by Optical Coherence Tomography Angiography in Idiopathic Intracranial Hypertension | Feyza Tüntaş Bilen; Huban Atilla | 2019-09 |
| 147 |
 |
Bariatric Surgery and the Neuro-Ophthalmologist | Heather E. Moss, MD, PhD | 2016-03 |
| 148 |
 |
The Idiopathic Intracranial Hypertension Treatment Trial: A Long-Time Coming but Worth the Wait | Roy W. Beck, MD, PhD | 2016-03 |
| 149 |
 |
Safety and Tolerability of Acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial | Martin W. ten Hove, MD; Deborah I. Friedman, MD; Anil D. Patel, MD; Isabella Irrcher, PhD; Michael Wall, MD; Michael P. McDermott, PhD; for the NORDIC Idiopathic Intracranial Hypertension Study Group | 2016-03 |
| 150 |
 |
Evaluation of a Significantly Shorter Version of the Farnsworth Munsell 100 Hue Test in Patients with Three Different Optic Neuropathies | Nichols, BE; Thompson, HS; Stone, EM | |
